期刊文献+

冠心病介入治疗致造影剂肾病98例临床分析 被引量:8

98 cases of contrast-induced nephropathy in patients who underwent coronary artery intervention
下载PDF
导出
摘要 目的探讨冠心病介入治疗发生造影剂肾病(CIN)的影响因素及预防措施。方法回顾性分析2008年1月—2009年12月1700例行冠心病介入治疗的患者,分析CIN发生的危险因素以及预防性措施。结果 CIN总发生率为5.76%(98/1700)。CIN组合并高血压病、糖尿病、原有肾功能不全病史比例明显高于非CIN组(P<0.05),而LVEF以及24 h水化量明显低于非CIN组(P<0.05)。结论冠心病介入术前应积极评估患者的危险因素,同时应用水化疗法预防,可以最大限度地改善及纠正危险因素,尽量避免CIN的发生。 Objective To investigate the influence factors and prevention of contrast-induced nephropathy(CIN) in patients who underwent coronary artery intervention.Methods 1700 patients who underwent PCI or coronary angiograph from January 2008 to December 2009 were enrolled in this study.Clinical characteristics,risk factors and preventive actions were investigated.Results Among the 1700 patients,98 patients(5.76%) developed CIN.Compared with the non CIN patients, the incidence of pre-existing renal dysfunction,hypertension,diabetes mellitus in CIN patients increased significantly(P0.05),the left ventricle ejective fraction and amount of hydration in 24 hours decreased significantly(P0.05).Conclusion Positive evaluating the risk factors and using hydration can effectively improve and correct risk factors and reduce the incidence of CIN in patients who would undergo coronary interventional therapy.
出处 《疑难病杂志》 CAS 2011年第3期171-172,共2页 Chinese Journal of Difficult and Complicated Cases
关键词 冠心病介入治疗 造影剂肾病 影响因素 预防 Coronary artery intervention therapy Contrast-induced nephropathy Influence factors Prevention
  • 相关文献

参考文献11

二级参考文献56

  • 1Rihal C S,Textor S C ,Grill D E ,et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention[ J ]. Circulation ,2002,105 ( 19 ) :2259-2264.
  • 2Safirstein R,Andrade L,Vieira J M. Acetylcysteine and nephrotoxic effects of radiographic contrast agents-a new use for an old drug[J]. N Engl J Med,2000,343(3) :210-212.
  • 3Kay J, Chow W H, Chan T M, et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial[ J]. JAMA ,2003,289(5 ) :553-558.
  • 4Gomes V O, Poli de Figueredo C E, Caramori P, et al. N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium : a muhicentre clinical trial [ J ]. Heart, 2005, 91 (6) :774-778.
  • 5Briguori C, Colombo A, Violante A, et al. Standard vs double dose of N-acetylcysteine to prevent contrast agent associated n eph rotoxicity [ J ]. Eur Heart J, 2004,25 ( 3 ) : 206-211.
  • 6Morcos S K. Prevention of contrast media nephrotoxicity--the story so far[ J]. Clin Radiol,2004,59(5 ) :381-389
  • 7Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies[J]. CMAJ,2005,172( 11 ) :1461-1471.
  • 8Haeussler U, Riedel M, Keller F. Free reactive oxygen species and nephrotoxicity of contrast agents [ J ]. Kidney Blood Press Res ,2004,27 ( 3 ) : 167-171.
  • 9Murphy S W, Barrett B J,Parfrey P S. Contrast nephropathy[ J]. J Am Soe Nephrol,2000,11 ( 1 ) : 177-182.
  • 10Hizoh I, Haller C. Radiocontrast-induced renal tubular cell apoptosis: hypertonic versus oxidative stress [ J ]. Invest Radiol,2002,37 ( 8 ) :428-434.

共引文献77

同被引文献99

引证文献8

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部